Showing results (111-120 of 484) with videos related to
Sort By:
Pageof 49
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.Journal of Diabetes Science and Technology|August 9, 2019
Prediction of Nocturnal Hypoglycemia From Continuous Glucose Monitoring Data in People With Type 1 Diabetes: A Proof-of-Concept StudyMorten H Jensen, Claus Dethlefsen, Peter Vestergaard, et al.Frontiers in Endocrinology|May 6, 2017
Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic ReviewJulius Simoni Leere, Jesper Karmisholt, Maciej Robaczyk, et al.Ugeskrift for Laeger|October 23, 2008
[Can measurement of basal calcitonin replace the pentagastrin test?]Peter Vestergaard, Asa Lina Jönsson, Peer Christiansen, et al.Journal of Diabetes Science and Technology|May 18, 2019
Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical TrialsMorten Hasselstrøm Jensen, Claus Dethlefsen, Ole Hejlesen, et al.Magma (New York, N.Y.)|July 11, 2006
The impact of susceptibility gradients on cartesian and spiral EPI for BOLD fMRIRyan Sangill, Mikkel Wallentin, Leif Østergaard, et al.World Journal of Surgery|May 8, 2007
Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?Peter Vestergaard, Else Marie Vestergaard, Helle Brockstedt, et al.Journal of Osteoporosis|July 22, 2011
The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in menPeter Schwarz, Niklas Rye Jorgensen, Leif Mosekilde, et al.Calcified Tissue International|January 13, 2012
Effects of increasing age, dosage, and duration of PTH treatment on BMD increase--a meta-analysisPeter Schwarz, Niklas Rye Jorgensen, Leif Mosekilde, et al.Pageof 49